Neurotransmitters and Cognitive Performance: What Dopamine, Serotonin, Acetylcholine and GABA Really Do

What neurotransmitters are and how they influence cognition

Neurotransmitters are released at the contact points between nerve cells (synapses) and bind to receptors on the next cell. Some act in a rather precise and rapid way, either exciting or inhibiting, while others work as so-called neuromodulators: they do not primarily alter individual signals but retune entire networks — adjusting, for instance, how awake, focused or ready to learn the brain currently is.

For cognition, a handful of systems are especially central. Glutamate is the most important excitatory messenger and GABA the most important inhibitory one; their balance determines whether a network operates stably or is over- or under-excited. Dopamine, serotonin and acetylcholine act predominantly as modulators and shape motivation, mood, attention and memory formation. The key point: these systems never work in isolation but in a dense interplay.

• Glutamate = excitatory, GABA = inhibitory; their balance stabilizes neural networks
• Dopamine, serotonin and acetylcholine act mainly as modulators
• Cognition arises from the interplay, not from a single messenger

Dopamine and the inverted-U principle

Dopamine is popularly regarded as the 'motivation and reward substance'. For demanding thought processes, its role in the prefrontal cortex is particularly well studied — and it is anything but linear. A widely cited review by Cools and D'Esposito (2011, Biological Psychiatry) describes, for working memory and cognitive control, a relationship shaped like an inverted U: both too little and too much dopamine impair performance; there is a middle, optimal range.

What is decisive here is the individual baseline. In studies, people with relatively low working memory benefited from dopamine-boosting substances, whereas the same substances actually worsened performance in people with a high baseline. This explains why blanket statements such as 'more dopamine = better thinking' are misleading: the same intervention can help or harm depending on the starting state.

• Dopamine's effect on working memory follows an inverted U
• Both too little and too much are unfavorable
• The individual baseline determines benefit or harm

Serotonin, acetylcholine and the GABA/glutamate balance

Serotonin is often reduced to the 'happiness hormone', which greatly oversimplifies the matter. It is involved in mood regulation, impulse control and sleep, and its effect depends on a wide variety of different receptors. The popular 'serotonin deficiency theory' of depression is now considered too simplistic; mood arises from complex networks, not from the level of a single substance.

Acetylcholine is closely linked to attention and learning. A review by Picciotto, Higley and Mineur (2012, Neuron) describes acetylcholine as a neuromodulator that improves the signal-to-noise ratio in the cortex, supports stimulus detection and promotes synaptic plasticity — the basis of learning. Short-term increases in the prefrontal cortex correlate with the detection of relevant stimuli.

GABA and glutamate, finally, form the foundation: glutamate drives activity and learning processes, while GABA keeps the system in check. If this balance is disturbed, focus, calm and information processing suffer — an excess of excitation is just as unfavorable as too much inhibition.

• Serotonin regulates mood, impulses and sleep — the 'deficiency theory' is considered outdated
• Acetylcholine improves attention, stimulus detection and learning ability
• The GABA/glutamate balance is the basis of stable network activity

The link to nootropic peptides: hypothesis rather than proof

From the central role of neurotransmitters, vendors and communities derive a link to so-called nootropic peptides — most often to Semax and Selank. Both originate from Russian research. Semax is a fragment analogue of the hormone ACTH; a review by Tsai (2007, Medical Hypotheses) notes that Semax can enhance the release of dopamine in animal models and stimulate the synthesis of the neurotrophic factor BDNF. Selank is an analogue of the peptide Tuftsin and is associated above all with the GABA system and likewise with BDNF.

The decisive perspective: a large part of these data comes from animal experiments and from clinical studies published predominantly in Russia and in Russian-language journals. High-quality, independently replicated, placebo-controlled studies on cognitive enhancement in healthy people are largely lacking. Mechanistic plausibility — that is, the fact that a substance influences a messenger system in cells or in animals — is not the same as a proven benefit in humans. Statements from forums and marketing should therefore be read as claims, not as established knowledge.

• Semax and Selank are associated with dopamine, GABA and BDNF
• A large part of the evidence comes from animal experiments and Russian-language studies
• Robust human studies on enhancement in healthy people are largely lacking
• A mechanism in the lab is not proof of benefit in humans

Status, risks and an honest perspective

From a regulatory standpoint, the situation is clear: in the EU, Semax and Selank are not approved medicines; they are registered in Russia as nasal sprays but count here as unapproved substances without officially reviewed efficacy and safety for use as 'brain doping'. Products sold online as 'research chemicals' are not subject to any pharmaceutical quality control — purity, dosage and contaminants are uncontrolled.

From this follows a sober assessment. Neurotransmitter research itself is solid and fascinating, but above all it teaches humility: more is not better, balance matters, and individual differences are large. The leap from this basic research to a concrete, safe and effective peptide product has so far not been convincingly demonstrated in humans. Anyone with cognitive or mood-related complaints should have them assessed by a doctor rather than relying on unregulated substances.

• No approved medicines in the EU; registered as nasal sprays in Russia
• 'Research' products sold online have no pharmaceutical quality control
• Basic research ≠ proven product benefit in humans
• For cognitive or mood complaints, seek medical assessment instead of self-experimentation